Exclusive: Pfizer, Ginkgo sign R&D deal worth up to $331M to develop RNA drugs (September 27, 2023) | By Andrew Dunn, Biopharma Correspondent In its latest Big Pharma deal, Ginkgo Bioworks will work with Pfizer to develop new RNA drugs, the Boston-based synthetic biology startup exclusively told Endpoints News. The two aren’t disclosing many specifics
Continue ReadingVIDEO: 9/6/2023 (September 6, 2023) | By Hersh Rephun. BRAND VOICE RUNWAY with Hersh Rephun (Season 1) Episode 9 – Ross Youngs Has the Molecular Cancer Moonshot. Now He Just Needs the Sound Bite. The next-figure for Ross Youngs, Founder and CEO of Biosortia, is not in dollars. In fact, 5 figures is plenty: specifically,
Continue Reading